(Q39982951)

English

Cross-reactive antibodies in middle-aged and elderly volunteers after MF59-adjuvanted subunit trivalent influenza vaccine against B viruses of the B/Victoria or B/Yamagata lineages

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Cross-reactive antibodies in middle-aged and elderly volunteers after MF59-adjuvanted subunit trivalent influenza vaccine against B viruses of the B/Victoria or B/Yamagata lineages (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

1 reference

based on heuristic

inferred from title

influenza vaccine

1 reference

based on heuristic

inferred from title

author name string

B Camilloni

1

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

M Neri

2

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

E Lepri

3

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

A M Iorio

4

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

language of work or name

0 references

publication date

14 May 2009

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

31

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

4099-4103

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Prevention and treatment of influenza

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.078

7 January 2021

Reappearance and global spread of variants of influenza B/Victoria/2/87 lineage viruses in the 2000-2001 and 2001-2002 seasons

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.078

7 January 2021

Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.078

7 January 2021

Mild to moderate influenza activity in Europe and the detection of novel A(H1N2) and B viruses during the winter of 2001-02

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.078

7 January 2021

Molecular characterization of influenza B viruses circulating in northern Italy during the 2001-2002 epidemic season

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.078

7 January 2021

Cocirculation and evolution of two lineages of influenza B viruses in europe and Israel in the 2001-2002 season

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.078

7 January 2021

Changes in the hemagglutinins and neuraminidases of human influenza B viruses isolated in Italy during the 2001-02, 2002-03, and 2003-04 seasons

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.078

7 January 2021

Seroprotection rate, mean fold increase, seroconversion rate: which parameter adequately expresses seroresponse to influenza vaccination?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.078

7 January 2021

The hemagglutinin of influenza B virus present in clinical material is a single species identical to that of mammalian cell-grown virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.078

7 January 2021

Antigenic and genetic characterization of the haemagglutinins of recent cocirculating strains of influenza B virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.078

7 January 2021

Cross-protection against influenza B type virus infection by intranasal inoculation of the HA vaccines combined with cholera toxin B subunit

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.078

7 January 2021

Secretory IgA antibodies provide cross-protection against infection with different strains of influenza B virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.078

7 January 2021

Serological responses in volunteers to inactivated trivalent subunit influenza vaccine: antibody reactivity with epidemic influenza A and B strains and evidence of a rapid immune response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.078

7 January 2021

Immune response to inactivated influenza virus vaccine: antibody reactivity with epidemic influenza B viruses of two highly distinct evolutionary lineages

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.078

7 January 2021

Response of influenza vaccines against heterovariant influenza virus strains in adults with chronic diseases.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.078

7 January 2021

Effects of repeated annual influenza vaccination on antibody responses against unchanged vaccine antigens in elderly frail institutionalized volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.078

7 January 2021

Identifiers

10.1016/J.VACCINE.2009.04.078

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39982951&oldid=1881707973"